跳至主要内容
临床试验/CTRI/2013/05/003607
CTRI/2013/05/003607招募中4 期

Efficacy and safety of Pentoxifylline and Prednisolone vs. Clofazimine and Prednisolone in the treatment of Type 2 Lepra reactions: a double blind randomized trial - L2PCS

Medical College Kolkata0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.All adult patients above 18 years of age presenting with type 2 lepra reaction
  • 2.patients giving informed written consent

排除标准

  • 1.Patient under 18 yrs.
  • 2.Patient not giving informed written consent
  • 3.Patients suffering from cardiac, hepatic, renal, neurological diseases, bleeding disorder, mental diseases, diabetes and/or immune-deficiencies related to HIV or not.
  • 4.Patients having any or history ofcerebrovascular disease
  • 5.Patients having history of hypersensitivity to methyl xanthine derivatives or Clofazimine.
  • 6.patients showing abnormal baseline laboratory parameters
  • 7.patients manifesting significant adverse effect of any drugs warranting discontinuation of therapy

研究者

相似试验